EquityZen Growth Technology Fund LLC - Series 1827
Raised
$159K
Investors
3
Min Invest
$255
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1827 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett. The entity raised $159K from 3 investors with a $255 minimum investment under Rule 506(b) and Section 3(c)(1). It is part of the EquityZen platform, which operates 1,889 related entities focused on pre-IPO secondary market access.
This pre-IPO pooled investment vehicle uses the standard 506(b)/3(c)(1) exemption pattern common to EquityZen's SPV structure. The $255 minimum investment reflects EquityZen's retail-accessible positioning, significantly lower than typical institutional pre-IPO funds, enabling fractional access to private growth company shares.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.